(Q33375739)

26 July 2017

1 reference

title

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? (English)

1 reference

26 July 2017

Batts ED

1

1 reference

26 July 2017

Lazarus HM

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

2 July 2007

1 reference

Bone Marrow Transplantation

26 July 2017

1 reference

26 July 2017

40

1 reference

26 July 2017

8

1 reference

26 July 2017

709-719

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705758

26 July 2017

0 references

cites work

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Transplantation-associated thrombotic microangiopathy: twenty-two years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Partial amino acid sequence of purified von Willebrand factor-cleaving protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic thrombocytopenic purpura following stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Endothelial damage caused by cytomegalovirus and human herpesvirus-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic microangiopathy in transplantation and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Procoagulant microparticles: disrupting the vascular homeostasis equation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Cyclosporine inhibits endothelial cell prostacyclin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Thrombotic microangiopathy of hyperacute onset after autologous peripheral blood stem cell transplantation in malignant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Oral eicosapentaenoic acid for complications of bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

A case of hemolytic uremic syndrome improved with nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Effects of atorvastatin on arterial endothelial function in coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Thrombotic thrombocytopenic purpura: a moving target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Recent advances in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Significance of elevation in cell-derived microparticles after allogeneic stem cell transplantation: transient elevation of platelet-derived microparticles in TMA/TTP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Toxicity of mitomycin C toward cultured pulmonary artery endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

The pathology of ionizing radiation as defined by morphologic patterns.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Cyclosporine toxicity on cultured rat microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705758

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705758

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference